NCT04002427View on ClinicalTrials.gov

Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

July 5, 2019

Study Completion Date

July 5, 2019

Conditions

Asthma

Interventions

DRUG

Intravenous Infusion

30 µg \[14C\]AZD7594 containing 6.7 kBq (180 nCi) carbon-14 (14C) as a 1 hour infusion.

DRUG

Inhaled dose

A single inhalation on one occasion.

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

AstraZeneca

INDUSTRY